Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27267375.
- Also identified by DOI 10.1093/ajcp/aqw051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To review the differential diagnosis and laboratory issues for women with a large calculated dose of Rh immune globulin (RhIG). A case-based approach is used to review the differential diagnosis of patients with a large calculated dose of RhIG, RhIG dosing for women with baseline elevations in hemoglobin F, the formulations of RhIG, and issues for the transfusion medicine service with the release of large doses of RhIG. A large fetomaternal bleed after delivery requiring multiple doses of RhIG is rare. Such patients may require intravenous RhIG to avoid multiple injections. Patients with a large percentage of circulating fetal RBCs should be evaluated for a disorder of hemoglobin synthesis and, if present, should have quantification of the circulating fetal RBCs by flow cytometry. Accurate laboratory evaluation of women with large fetomaternal bleeds is essential for appropriate RhIG administration.
Medical subject headings
- Rho(D) Immune Globulin